Suppr超能文献

欧洲医院成为多重耐药菌的源头:对在芬兰住院后出国旅行的旅行者进行筛查的分析。

European hospitals as source of multidrug-resistant bacteria: analysis of travellers screened in Finland after hospitalization abroad.

机构信息

Department of Infectious Diseases, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Meilahti Infectious Diseases and Vaccine Research Center, MeiVac, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

出版信息

J Travel Med. 2022 Jul 14;29(4). doi: 10.1093/jtm/taac022.

Abstract

BACKGROUND

As hospitals have a high prevalence of multidrug-resistant organisms (MDRO), hospitalization abroad indicates for travellers an increased risk of acquiring MDRO-and carrying the strains home. Antimicrobial resistance (AMR) rates are highest in the (sub)tropics, whereas Europe is considered a lower risk region. Since AMR prevalences vary within Europe, we aimed to gather country-specific data on the risks for hospitalized travellers.

METHODS

At hospitals of the Helsinki and Uusimaa district in Finland, patients hospitalized abroad over the past 12 months are systematically screened for methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales (ESBL-PE), carbapenemase-producing bacteria and vancomycin-resistant Enterococcus spp. (VRE). Among patients screened 2010-19, we selected those hospitalized in Europe, recorded their MDRO findings, infections and mortality, and analysed MDRO-associated risk factors.

RESULTS

Of the 1772 patients treated in 41 European countries, 16.6% (295) carried MDRO, 12.5% (221) ESBL-PE, 7.8% (138) solely ESBL-E. coli, 2.6% (46) MRSA, 2.2% (30) of those screened VRE and 2.2% (39) carbapenem-resistant Gram-negatives. Among those colonized, 9.8% (29) had symptomatic MDRO infections and 0.3% (one) died. Colonization was most frequently recorded for those treated in eastern and southern Europe, with Bulgaria, Cyprus and the Russian Federation scoring highest. MDRO colonization was associated with antibiotic treatment and showed a negative correlation with time from discharge to screening.

CONCLUSIONS

After hospitalization in European countries, ESBL-PE carriage was relatively common (12.5%), while other MDROs proved less frequent (<5%). Antibiotic treatment and short time since hospitalization abroad increased the risk of MDRO colonization. Clear differences between countries and regions were revealed, with highest rates in the east and the south.

摘要

背景

由于医院普遍存在多重耐药菌(MDRO),因此出国就医的旅行者面临更高的感染 MDRO 并将耐药菌携带回家的风险。抗生素耐药性(AMR)率在(亚热带)热带地区最高,而欧洲被认为是低风险地区。由于欧洲内部的 AMR 流行率存在差异,我们旨在收集有关住院旅行者风险的特定国家数据。

方法

在芬兰赫尔辛基和乌西玛地区的医院,系统地对过去 12 个月内在国外住院的患者进行筛查,以检测耐甲氧西林金黄色葡萄球菌(MRSA)、产超广谱β-内酰胺酶(ESBL)的肠杆菌科(ESBL-PE)、产碳青霉烯酶细菌和万古霉素耐药肠球菌(VRE)。在筛查的 2010-19 年期间,我们选择了在欧洲住院的患者,记录了他们的 MDRO 检测结果、感染和死亡率,并分析了 MDRO 相关的危险因素。

结果

在来自 41 个欧洲国家的 1772 名患者中,16.6%(295 人)携带 MDRO,12.5%(221 人)携带 ESBL-PE,7.8%(138 人)仅携带产 ESBL 的大肠埃希菌,2.6%(46 人)携带 MRSA,2.2%(30 人)筛查出 VRE,2.2%(39 人)携带耐碳青霉烯类的革兰氏阴性菌。在定植的患者中,9.8%(29 人)有症状性 MDRO 感染,0.3%(1 人)死亡。在东欧和南欧国家,定植的情况最为常见,保加利亚、塞浦路斯和俄罗斯联邦的得分最高。MDRO 定植与抗生素治疗有关,与从出院到筛查的时间呈负相关。

结论

在欧洲国家住院后,ESBL-PE 携带较为常见(12.5%),而其他 MDRO 则相对较少(<5%)。抗生素治疗和短时间的国外住院增加了 MDRO 定植的风险。结果显示,各国和各地区之间存在明显差异,东欧和南欧的比率最高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1899/9282090/1c314dff15ab/taac022f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验